The global cardiac biomarkers market is estimated to be valued at US$ 8,099.9 million in 2021 and is expected to exhibit a CAGR of 10.2% over the forecast period, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Cardiac biomarkers are protein-based substances that are released into the blood when the heart is damaged or stressed. These biomarkers help diagnose cardiac ischemia and acute coronary syndrome (ACS), conditions associated with insufficient blood flow to the heart. They are also used to manage and diagnose patients with pulmonary embolism, acute heart failure, and other conditions. They are used as risk stratification for various cardiovascular diseases. Biomarkers that are widely used as an integrated diagnostic approach for cardiovascular diseases (CVDs) include troponin I and T, CK-MB, myoglobin, IMA, BNPs, and few others. Cardiac biomarkers play an important role in the diagnosis, risk stratification, management, and clinical decision-making in patients suffering from CVDs.
Get FREE Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4576
Competitive Landscape:
Major players operating in the global cardiac biomarkers market are BioMérieux SA, Siemens Healthineers, Randox Laboratories Ltd., Danaher Corporation, F. Hoffmann-La Roche AG, Abbott Laboratories, Bio-Rad Laboratories, and Thermo Fisher Scientific Inc., among others.
Key Market Drivers:
Increasing prevalence of cardiovascular diseases around the world is expected to augment the growth of the cardiac biomarkers market during the forecast period. For instance, according to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death worldwide, around 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke.
Moreover, introduction of novel biomarkers, increasing research and development activities, and technological advancements in the cardiac biomarkers are expected to drive growth of the cardiac biomarkers market. For instance, in April 2018, Roche announced a series of five new intended uses for two key cardiac biomarkers using Elecsys technology: high sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). These biomarkers have proven to be successful in supporting cardiovascular disease management and can help clinicians diagnose heart attacks and better manage heart failure.
COVID-19 Impact Analysis:
According to WHO, older people, and those with underlying medical problems, such as cardiac disease, diabetes, cancer, and chronic respiratory disease are at high risk of developing serious illness from COVID-19. The virus can cause acute myocardial injury and chronic damage to the cardiovascular system. For instance, in November 2021, European Society of Cardiology (ESC) guidance launched for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic.
Key Takeaways:
- The cardiac biomarkers market is expected to exhibit a CAGR of 10.2 % during the forecast period due to the increasing adoption of point-of-care biomarker tests across the globe. For instance, in June 2018, King’s College London researchers developed a point-of-care blood test to diagnose heart attacks that uses cardiac myosin-binding protein C as an alternative biomarker to high-sensitivity troponin used in laboratory testing.
- Among regions, North America, Europe, and Asia Pacific are expected to witness robust growth in the cardiac biomarkers market due to the increasing prevalence of cardiovascular diseases, increasing research and development activities, introduction of novel biomarkers, and technological advancements in the cardiac biomarkers in these region. For instance, in September 2018, Abbott announced that its High Sensitive Troponin-I blood test is the first troponin test with CE Mark that can more accurately predict the chances of having a heart attack or other cardiac event potentially months to years in advance.
Moreover, in September 2019, Abbott received the Food and Drug Administration (FDA) approval for high sensitivity Troponin-I blood test that help detect heart attacks faster and accurately than contemporary troponin tests. Furthermore, in July 2018, Siemens received FDA approval of high-sensitivity Troponin I assays that help diagnose patients with acute myocardial infarction (MI).
Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4576
Reasons to Purchase this Report
• Current and future of global Cardiac Biomarkers Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!!!!!!!
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Purchase This Premium Report With Discounted Rate @ https://www.coherentmarketinsights.com/insight/buy-now/4576
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Location of Testing
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Porters Five Forces analysis
- Market Trends
- Key highlights
- Supply chain analysis
- Epidemiology
- Regulatory scenario
- PEST Analysis
- Market Dynamics
- Global Cardiac Biomarkers Market – Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact of COVID-19 on healthcare sector
- Impact on cardiac biomarkers market
- Impact on demand and supply of cardiac biomarker
- Global Cardiac biomarkers market, by Product Type,2017 –2028 (US$ Million
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Myocardial Muscle Creatine Kinase (CK-MB)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn
- Troponins (T and I)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Myoglobin
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million
- Ischemia-modified Albumin (IMA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Cardiac Biomarkers Market, By Application, 2017 –2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Myocardial Infarction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Congestive Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Acute Coronary Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Atherosclerosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Cardiac Biomarkers Market, By Location of Testing, 2017 –2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Laboratory Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Point-of-Care Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Cardiac Biomarkers Market, By Region, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Region/Countries, 2017 – 2028, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- Introduction
View Press Release For More Information: https://www.coherentmarketinsights.com/press-release/cardiac-biomarkers-market-3822
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837